ICL reports Q2 2026 sales higher by 17% to $2.1 billion

ICL reported Q2 2026 sales of $2.1 billion, up 17% from $1.8 billion a year earlier, citing stronger pricing and demand. Operating income rose to $266 million from $181 million, and net income to $137 million from $93 million. Adjusted EBITDA was $448 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5 billion to $1.7 billion and potash volumes of 4.5 to 4.7 million metric tons.

Original reporting
Published Aug 6, 2026, 4:16 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 7:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ICL reports Q2 2026 sales higher by 17% to $2.1 billion — source image
Decision brief

The 30-second read

$ICLBullishMed
01

Why it matters

The combination of higher sales, improved operating income and net income, higher adjusted EBITDA, and stronger free cash flow supports a positive earnings-quality narrative. Reiterated full-year adjusted EBITDA guidance and potash volume expectations provide a concrete anchor for forward estimates, while Elevate’s quantified annualized savings target adds a measurable margin/cash catalyst into 2027-2028.

02

Market read

Traders can update near-term earnings and margin expectations using the Q2 datapoints and the reiterated 2026 EBITDA and potash volume ranges, plus the Elevate savings timeline.

03

What to watch

The article reiterates EBITDA and potash volume ranges but does not quantify segment margins or any guidance sensitivity; traders may need to watch for execution risk in the 2027 organizational realignment and Elevate savings ramp.

Relevance 7/10Novelty 7/10Timing: pre-market today (Q2 results and 2026 guidance reiterated)

Background

ICL is a global specialty minerals company reporting Q2 2026 results and outlining a 2027 organizational realignment plus an enterprise cost-savings program (Elevate).

Company-level read

Ticker impact

$ICLBullishMedium confidence
Context

ICL reported Q2 2026 sales of $2.1B (+17% YoY) and raised operating income and net income, signaling stronger demand and pricing.

Expected impact

Likely positive bias for ICL shares on earnings-quality and margin/cash-flow momentum, with follow-through tied to 2027 cost-savings execution.

Evidence & confidence

The article provides multiple concurrent datapoints (sales, operating income, net income, EBITDA, FCF) plus reiterated full-year guidance and a quantified Elevate savings target, which traders can map to margin and cash-generation expectations.

Market effects

Specialty minerals and fertilizer-linked names may see read-across from ICL’s pricing strength, demand commentary, and cost-savings plan.

Limited direct regional spillover stated, but improved cash generation can influence sentiment toward global specialty-mineral exporters.

Global agriculture and industrial end-market demand signals could modestly affect sentiment across fertilizer and specialty minerals supply chains.

Counterpoint

Strong Q2 growth may partly reflect pricing normalization or timing effects; the market may discount results if cost-savings delivery slips into later quarters.

Key entities

  • ICL

    Reports Q2 2026 sales growth, improved profitability and cash flow, reiterates 2026 adjusted EBITDA guidance, and details Elevate cost savings and a 2027 organizational structure.

Related articles

$ICLMedAI 8/10

ICL (ICL) Q2 2026 Earnings Call Transcript

ICL Group reported Q2 2026 sales of $2.1 billion, up 17%, and adjusted EBITDA of $448 million, up 28%, citing higher potash, bromine and phosphate prices. Adjusted net income rose 35% to $149 million, and adjusted EPS rose 33% to $0.12. Free cash flow was $94 million. Full-year 2026 EBITDA guidance was reiterated at $1.5 billion to $1.7 billion.

$ICLMedAI 8/10

ICL Group LTD: ICL Reports Second Quarter 2026 Results

ICL Group (NYSE: ICL) reported Q2 2026 results for the quarter ended June 30, 2026. Consolidated sales rose to $2.1 billion (+17% Y/Y). Operating income increased to $266 million from $181 million, and net income attributable to shareholders rose to $137 million from $93 million. ICL reiterated FY2026 adjusted EBITDA guidance of $1.5B to $1.7B and expects potash volumes of 4.5 to 4.7 million metric tons.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.